Petar Alaupovic

14.4k total citations
231 papers, 11.8k citations indexed

About

Petar Alaupovic is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Petar Alaupovic has authored 231 papers receiving a total of 11.8k indexed citations (citations by other indexed papers that have themselves been cited), including 120 papers in Surgery, 115 papers in Endocrinology, Diabetes and Metabolism and 57 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Petar Alaupovic's work include Diabetes, Cardiovascular Risks, and Lipoproteins (107 papers), Lipoproteins and Cardiovascular Health (95 papers) and Cancer, Lipids, and Metabolism (55 papers). Petar Alaupovic is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (107 papers), Lipoproteins and Cardiovascular Health (95 papers) and Cancer, Lipids, and Metabolism (55 papers). Petar Alaupovic collaborates with scholars based in United States, Sweden and Canada. Petar Alaupovic's co-authors include Walter J. McConathy, Ola Samuelsson, Diana M. Lee, Michael D. Curry, Carolyn Knight‐Gibson, Per‐Ola Attman, W.J. McConathy, Wendy J. Mack, Anders Gustafson and David H. Blankenhorn and has published in prestigious journals such as Science, New England Journal of Medicine and Circulation.

In The Last Decade

Petar Alaupovic

228 papers receiving 11.0k citations

Peers

Countries citing papers authored by Petar Alaupovic

Since Specialization

Citations

This map shows the geographic impact of Petar Alaupovic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Petar Alaupovic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Petar Alaupovic more than expected).

Fields of papers citing papers by Petar Alaupovic

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Petar Alaupovic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Petar Alaupovic. The network helps show where Petar Alaupovic may publish in the future.

Co-authorship network of co-authors of Petar Alaupovic

This figure shows the co-authorship network connecting the top 25 collaborators of Petar Alaupovic. A scholar is included among the top collaborators of Petar Alaupovic based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Petar Alaupovic. Petar Alaupovic is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	LpA-II:B:C:D:E: a new immunochemically-defined acute phase lipoprotein in humans 2018 ·Lipids in Health and Disease ·John D. Bagdade, Bernd Jilma, Lisa C. Hudgins, Petar Alaupovic, Carrie E. McCurdy	3
2	Dose-response effects of marine omega-3 fatty acids on apolipoproteins, apolipoprotein-defined lipoprotein subclasses, and Lp-PLA2 in individuals with moderate hypertriglyceridemia 2014 ·Journal of clinical lipidology ·Ann C. Skulas‐Ray, Petar Alaupovic, Penny M. Kris‐Etherton, Sheila G. West	23
3	Dual PPARα/γAgonism Normalizes Lipoprotein Profile of Renal Dyslipidemia 2013 ·PPAR Research ·Ola Samuelsson, P.-O. Attman, Ingrid Gause‐Nilsson, Maria Svensson, Petar Alaupovic	3
4	Sex differences in HDL ApoC-III in American Indian youth 2012 ·Biology of Sex Differences ·Piers R. Blackett, Sohail Khan, Wenyu Wang, Petar Alaupovic, Elisa T. Lee	0
5	Apolipoprotein-defined lipoprotein abnormalities in rheumatoid arthritis patients and their potential impact on cardiovascular disease 2012 ·Scandinavian Journal of Rheumatology ·Nicholas Knowlton, (unknown), Michael Centola, Petar Alaupovic	16
6	High-Dose B Vitamin Supplementation and Progression of Subclinical Atherosclerosis 2008 ·Stroke ·Howard N. Hodis, Wendy J. Mack, (unknown), Peter R. Mahrer, Stanley P. Azen, Robert Detrano, Jacob Selhub, Petar Alaupovic, Chaoran Liu, Liu Ci-hua, Juliana Hwang, Alison Wilcox, Robert H. Selzer	102
7	Characterization of the Metabolic Syndrome by Apolipoproteins in the Oklahoma Cherokee 2008 ·PubMed ·Petar Alaupovic, Piers R. Blackett, Wenyu Wang, Elisa Lee	7
8	Effects of pistachios on cardiovascular disease risk factors and potential mechanisms of action: a dose-response study 2008 ·American Journal of Clinical Nutrition ·Sarah K Gebauer, Sheila G. West, Colin D. Kay, Petar Alaupovic, Deborah Bagshaw, Penny M. Kris‐Etherton	113
9	Body Mass Index and High-Density Lipoproteins in Cherokee Indian Children and Adolescents 2005 ·Pediatric Research ·Piers R. Blackett, (unknown), (unknown), Wenyu Wang, (unknown), Petar Alaupovic, Elisa T. Lee	9
10	ApoC-III bound to apoB-containing lipoproteins increase with insulin resistance in Cherokee Indian youth 2005 ·Metabolism ·Piers R. Blackett, (unknown), (unknown), (unknown), Wenyu Wang, Petar Alaupovic, Elisa T. Lee	15
11	A comparison of pravastatin and gemfibrozil in the treatment of dyslipoproteinemia in patients with non-insulin-dependent diabetes mellitus 2002 ·Atherosclerosis ·(unknown), Daniel Tessier, (unknown), Lawrence A. Leiter, Jean Paul Collet, Matthew McQueen, (unknown), Petar Alaupovic	20
12	Metabolic and Antihypertensive Effects of Nebivolol and Atenolol in Normometabolic Patients with Mild-to-Moderate Hypertension 1999 ·American Journal of Therapeutics ·Yves Pesant, J Marc-Aurèle, (unknown), Petar Alaupovic, P Cartier, Daniel G. Bichet, Gaétan Thibault, Paul J. Lupien	21
13	750-3 The Role of Triglyceride-Rich Lipoprotein Families in the Progression of Coronary Artery Atherosclerotic Lesions 1995 ·Journal of the American College of Cardiology ·Howard N. Hodis, Wendy J. Mack, Carolyn Knight‐Gibson, Petar Alaupovic	1
14	Isolation and partial characterization of lipoprotein A-II (LP-A-II) particles of human plasma 1992 ·Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism ·(unknown), Petar Alaupovic, Carolyn Knight‐Gibson, Robert A. Norum, (unknown), M Ayrault-Jarrier	33
15	Lipid and Apolipoprotein Profiles of Uremic Dyslipoproteinemia -Relation to Renal Function and Dialysis 1991 ·The Nephron journals/Nephron journals ·Per-Ola Attman, Petar Alaupovic	142
16	ApoB-Containing Lipoprotein Particles as Risk Factors for Coronary Artery Disease 1990 ·Advances in experimental medicine and biology ·Petar Alaupovic, (unknown), Carolyn Knight‐Gibson, Marcelo Tavella, Jean‐Marie Bard, David Shafer, (unknown), (unknown)	14
17	Profiles of apolipoproteins and apolipoprotein B-containing lipoprotein particles in dyslipoproteinemias. 1988 ·PubMed ·Petar Alaupovic, (unknown), J.D. Fesmire, Marcelo Tavella, Jean‐Marie Bard	53
18	Serum apolipoprotein profile of patients with chronic renal failure 1987 ·Kidney International ·Per‐Ola Attman, Petar Alaupovic, Anders Gustafson	83
19	Effects of saturated, monounsaturated, and ω-6 polyunsaturated fatty acids on plasma lipids, lipoproteins, and apoproteins in humans 1983 ·American Journal of Clinical Nutrition ·Nils Becker, D. Roger Illingworth, Petar Alaupovic, Connor We, (unknown)	135
20	Isolation and partial characterization of apolipoprotein D: A new protein moiety of the human plasma lipoprotein system 1973 ·FEBS Letters ·W.J. McConathy, Petar Alaupovic	171

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact